Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Drug & Device News
One Manufacturer Settles With Thousands of Transvaginal Mesh Claimants
American Medical Systems Inc. (AMS), a subsidiary of Endo International PLC, announced April 30 that it had settled 20,000 claims against it brought by users of its transvaginal mesh devices. These devices, which are used to treat pelvic organ prolapse and urinary incontinence, have caused patients to suffer bleeding and pain, the plaintiffs say. For some, additional surgery to remove the devices has been required. AMS's $830 million settlement is the largest to result from the thousands of transvaginal mesh injury suits recently lodged against several device manufacturers, including Johnson & Johnson and Boston Scientific Corp. Those larger companies are not expected to follow AMS's lead.
“It's going to be a busy year,” said Harry Bell of The Bell Law Firm in Charleston, WV, liaison co-counsel for the plaintiffs in the mesh litigation. “The landscape of TVM [transvaginal mesh] is going to be drastically different at the end of the year. We've already seen one huge change,” said Bell, referring to the AMS settlement. “The official position of the other defendants ' we're talking about Bard, Ethicon, and Boston Scientific ' is they are prepared to fight this,” Bell said. “They think ' there's nothing wrong with [their products], and they're aggressively fighting ' .”
One Manufacturer Settles With Thousands of Transvaginal Mesh Claimants
“It's going to be a busy year,” said Harry Bell of The Bell Law Firm in Charleston, WV, liaison co-counsel for the plaintiffs in the mesh litigation. “The landscape of TVM [transvaginal mesh] is going to be drastically different at the end of the year. We've already seen one huge change,” said Bell, referring to the AMS settlement. “The official position of the other defendants ' we're talking about Bard,
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
'Huguenot LLC v. Megalith Capital Group Fund I, L.P.': A Tutorial On Contract Liability for Real Estate Purchasers
In June 2024, the First Department decided Huguenot LLC v. Megalith Capital Group Fund I, L.P., which resolved a question of liability for a group of condominium apartment buyers and in so doing, touched on a wide range of issues about how contracts can obligate purchasers of real property.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
CoStar Wins Injunction for Breach-of-Contract Damages In CRE Database Access Lawsuit
Latham & Watkins helped the largest U.S. commercial real estate research company prevail in a breach-of-contract dispute in District of Columbia federal court.